An elevated level of cholesterol impairs self-assembly of pulmonary surfactant into a functional film.
about
Ionizable Nitroxides for Studying Local Electrostatic Properties of Lipid Bilayers and Protein Systems by EPRComparative study of clinical pulmonary surfactants using atomic force microscopyAtomic force microscopy of biological samples.ATP-binding cassette transporter G1 deficiency dysregulates host defense in the lungA ToF-SIMS study of the lateral organization of lipids and proteins in pulmonary surfactant systems.Pulmonary abnormalities in animal models due to Niemann-Pick type C1 (NPC1) or C2 (NPC2) diseaseActivation of sterol-response element-binding proteins (SREBP) in alveolar type II cells enhances lipogenesis causing pulmonary lipotoxicity.Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometerSerum Lipoproteins Are Critical for Pulmonary Innate Defense against Staphylococcus aureus Quorum Sensing.Surface electrostatics of lipid bilayers by EPR of a pH-sensitive spin-labeled lipid.Atomic force microscopy studies of functional and dysfunctional pulmonary surfactant films. I. Micro- and nanostructures of functional pulmonary surfactant films and the effect of SP-A.Atomic force microscopy studies of functional and dysfunctional pulmonary surfactant films, II: albumin-inhibited pulmonary surfactant films and the effect of SP-ADyslipidemia induces opposing effects on intrapulmonary and extrapulmonary host defense through divergent TLR response phenotypesLipid-lowering drug therapies and chronic obstructive pulmonary disease: lung failure or just heart failure?Metabolomics analysis reveals that benzo[a]pyrene, a component of PM2.5, promotes pulmonary injury by modifying lipid metabolism in a phospholipase A2-dependent manner in vivo and in vitro.The molecular mechanism of monolayer-bilayer transformations of lung surfactant from molecular dynamics simulations.Lung surfactant protein SP-B promotes formation of bilayer reservoirs from monolayer and lipid transfer between the interface and subphase.Palmitoylation of pulmonary surfactant protein SP-C is critical for its functional cooperation with SP-B to sustain compression/expansion dynamics in cholesterol-containing surfactant films.Effect of Lung Surfactant Protein SP-C and SP-C-Promoted Membrane Fragmentation on Cholesterol Dynamics.Surfactant protein C peptides with salt-bridges ("ion-locks") promote high surfactant activities by mimicking the α-helix and membrane topography of the native proteinSP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance.Role of cholesterol in the biophysical dysfunction of surfactant in ventilator-induced lung injury.Alterations to surfactant precede physiological deterioration during high tidal volume ventilation.Divide & Conquer: Surfactant Protein SP-C and Cholesterol Modulate Phase Segregation in Lung Surfactant.Amyloid-β (1-40) restores adhesion properties of pulmonary surfactant, counteracting the effect of cholesterol.Inhibition and counterinhibition of Surfacen, a clinical lung surfactant of natural origin
P2860
Q28828128-014C2955-0393-442B-9D2E-568A01A81ED0Q28833705-0B10C4AE-C974-4AB6-8710-4A4282323D00Q33645531-3B9C0E40-3F6B-43D4-B415-2242CD1D5C28Q34065631-BFDA4380-0FD3-4546-B558-BDF4D6252411Q34583609-2D89593C-8CE1-4C7F-ACB5-487902EBE94CQ34812413-8EC0D141-C42F-4CD2-955A-F6AD850CD977Q35880146-68BEC8C7-367A-422C-841E-96296EFF307AQ36318031-EB14D09F-DBFA-49BC-942C-7D4CF978A445Q36387278-0992BFED-D205-4708-8A30-CCC9EDC3F0EDQ36518518-3074BE10-57E2-4B7F-8365-69EE8A1D0568Q36538215-EC8BF891-2E79-478F-A758-CB25C67A684DQ36856485-0FC5FD7E-053C-4ED4-975D-6E21D61EF558Q37648984-29A155E4-DAE1-47F1-9CD9-29612B3848C0Q38181583-520099E8-D41A-4B2C-87E2-0C6591815E8EQ38697087-DAAB93CF-8BB8-4466-8282-7D192F6B5C1DQ40320317-414A2129-8E01-45EB-A8E0-CA3327217E0EQ41864922-8B71BEE0-917A-4C17-809D-E030FA8B5AA8Q42364805-0C0BAAF8-4C81-4014-80FE-4627A16F5B8FQ42381304-F2162484-96A7-42C4-BAD5-751763B2E4EEQ42742507-903BB4DE-A758-4CE6-8974-068A977A7DEBQ42936088-34191C7F-8272-4E74-ADAA-EAA2BEC6A4C8Q43246210-57274EE5-9212-4499-A7F0-C54C90743EC8Q46698806-4B164409-9206-4A0E-9C25-4B7AFA61778FQ47794700-07940DFB-2BBA-422A-9AE8-FDFDAB0D055AQ51715796-A5B18213-8082-446F-A683-87E9CB8CFF73Q58713589-69C32DF7-7BF5-4940-9EA3-8FD66C8D07F3
P2860
An elevated level of cholesterol impairs self-assembly of pulmonary surfactant into a functional film.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
An elevated level of cholester ...... actant into a functional film.
@ast
An elevated level of cholester ...... actant into a functional film.
@en
type
label
An elevated level of cholester ...... actant into a functional film.
@ast
An elevated level of cholester ...... actant into a functional film.
@en
prefLabel
An elevated level of cholester ...... actant into a functional film.
@ast
An elevated level of cholester ...... actant into a functional film.
@en
P2093
P2860
P1433
P1476
An elevated level of cholester ...... actant into a functional film.
@en
P2093
Florian Felderer
Jana Doehner
Lasantha Gunasekara
Luca Monticelli
Lukas M Eng
Mathias Rodenstein
Matthias Amrein
Simardeep Gill
Zoya Leonenko
P2860
P304
P356
10.1529/BIOPHYSJ.107.106310
P407
P577
2007-05-04T00:00:00Z